Risk of Sexual Transmission under HAART Background information on Swiss statement Pietro Vernazza President EKAF- Swiss Federal Commission on AIDS.

Slides:



Advertisements
Similar presentations
Main Menu UIC / HBHC Treatment Advocacy Program TAP: Sexual safety 2 12/9/03 1 The University of Illinois at Chicago Howard Brown Health Center Treatment.
Advertisements

The Connection Between STDs and HIV
Factors Associated with Potential Exposure to and Transmission of HIV in a Probability Sample of Men Who Have Sex with Men Devon D. Brewer Matthew R. Golden.
HIV treatment as prevention Stephen Kegg. 2 Learning Outcomes Overview of HIV management HIV transmission risks Current prevention strategies Which new.
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
Monica Gandhi MD, MPH Associate Professor and Women’s HIV Clinic provider, HIV/AIDS Division San Francisco General Hospital/ UCSF Safe Poz Love, U.S. Positive.
Transmission risk between couples: the “science” Martin Fisher Brighton and Sussex University Hospitals NHS Trust Gus Cairns National AIDS Manual.
Field Based Treatment of Chlamydia and Gonorrhea Nilmarie Guzmán,MD & Michael Sands,MD University of Florida/Jacksonville and the Duval County Health Department.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
What is the risk of acquiring HIV from oral sex? Workshop Ground Rules Confidentiality Use “I” statements Pass if you want Agree to Disagree Leave PC.
HIV INTERVENTION FOR PROVIDERS (HIP) Principal Investigators:  Carol Dawson Rose, RN, Ph.D. and Grant Colfax, MD. Co-Investigators:  Cynthia Gomez, Ph.D.,
Barebacking: A Harm Reduction Approach Paul Quick, M.D. Tom Waddell Health Center San Francisco Department of Public Health
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 7.
Incorporating HIV Prevention into the Medical Care of Persons Living with HIV Ask ∙ Screen ∙ Intervene Developed by: The National Network of STD/HIV Prevention.
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
Rusty Bennett 9 th Grade Health. STDs are diseases that you get by having sexual contact (vaginal, oral, or anal) with someone who already has an STD.
Undetectable = Uninfectious ? Treatment as Prevention.
Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma Marcelin AG 1, Tubiana R 1, Lambert-Niclot.
HIV/AIDS Presented by Kunphen center for substance dependence and HIV/AIDS.
Population-level Effect of Free Access to HAART on Reducing HIV Transmission in Taiwan 2013 International Conference on Global Health: HIV: Seek, test,
FEEDBACK Living 2008 Summit & XVII International AIDS Conference Universal Action Now Mexico City August 2008 Silvia Petretti Community Development Manager.
Management of the Newly Diagnosed Patient. Jane Bruton Clinical Research Nurse Imperial College.
Sexually Transmitted Infections. What is a Sexually Transmitted Infection or STI? STI’s are infections that are spread from person to person through.
RESULTS METHODS Pre-exposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child P. Vernazza 1 I. Brenner 1, I. Graf.
What do models estimate to be the impacts on HIV incidence of various percentages of people with HIV on ART ? National AIDS Trust Treatment as Prevention.
Dr.Bujji Babu M.D. Bujjibabu HIV Clinic. HIV / STD Among the three modes of transmission of HIV viz. Blood borne, Vertical and Sexual, SEXUAL TRANSMISSION.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
SEXUALLY TRANSMITTED DISEASES
Ethical considerations on HIV and Syphilis research in indigenous communities in Peru Instituto Nacional de Salud Ministerio de Salud PERÚ Centro Nacional.
JORDAN E. LAKE, MD, MSC AAHU SEPTEMBER 2014 Prevention for Positives.
1 HIV Prevention for Patients and the Community HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Implementation of HIV Treatment as Prevention in China Yan Zhao MD National Center for AIDS/STD Control & Prevention Chinese Center for Disease Control.
HIV-infected subjects with CD4 350 to 550 cells/mm serodiscordant couples HPTN 052 Study Design Immediate ART CD Delayed ART CD4
Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London.
Reproductive Health and Safety Education. What is “Making Proud Choices?” We will talk about HIV-the virus that causes AIDS, other STDs, and teen pregnancy.
PhD We knew nothing about the set-point viral loads. What was unknown about HIV-1 infection before this paper was published in 2007? 1.Virus density.
Evaluating the Use of HIV Surveillance Data for Initiating Partner Services in Houston, Texas, US 2012 International AIDS Conference Washington, D.C. Shirley.
Providing Treatment, Restoring Hope Secondary Prevention as part of HIV Clinical Care Martine Etienne, MPH, DrPH University of Maryland School of Medicine.
JORDAN E. LAKE, MD, MSC AAHU AUGUST 2015 Prevention for Positives.
ARV-Based Prevention: Perspective from Epidemiology & Modelling Tim Hallett Imperial College London.
Undetectable= Uninfectious? Community Response To “The Swiss Statement” Women’s perspective Silvia Petretti Positively Women, Community Development Manager.
Monodisciplinary, Multidisciplinary, Interdisciplinary, and Transdisciplinary Approaches to Reproductive Health Research II William A. Fisher, Ph.D Department.
PrEP Update: The science, new tools, and next steps Dawn K. Smith MD, MS, MPH Division of HIV/AIDS Prevention, CDC “The findings and conclusions in this.
Grinsztejn B, et al, Lancet Infect Dis, March 4 th 2014 PRIMARY COMBINED M&M OUTCOME FIRST AIDS DEFINING EVENT FIRST TB EVENT DEATH.
HOPE YOU ARE HAVING A GREAT WEEK! What is something new you have learned?
Antiretrovirals for HIV Prevention: Progress and Challenges Kenneth H. Mayer, M.D. Brown/Miriam/Fenway.
Ceri Evans Senior Sexual Health Adviser West London Centre for Sexual Health Chelsea and Westminster Hospital Foundation Trust.
Research to design community based prevention IAS Satellite – July 17, 2011 “Controlling the HIV epidemic – The promise of ARV-based prevention”
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
Expanded PrEP implementation across Australia Expanded implementation of PrEP across Australia 1.
Information about HIV Prevention Options
COMBINATION PREVENTION
Provider Initiated HIV Counseling and Testing
Dr. Venkatesan Chakrapani, MD
MTN-025 (HOPE Study) Community Education Presentation
PrEP: A Case-by-Case Approach
HIV and the ART of Prevention
John de Wit1,2, Dean Murphy2,3, Luxi Lal4,5,6, Jennifer Audsley5,7, Christopher K. Fairley8,9, Mark Stoove4,10, Norm Roth11, Richard Moore12, Ban K.
THE AFRICAN EYE TRUST HIV/AIDS in 2007: A Complex Picture
PrEP.
S.13 The Local and Global Impact of HIV
Secondary Prevention.
HIV.
Analytic framework illustrating exposure to preventive measures that reduce the risk of transmission between HIV-serodiscordant sex partners. Analytic.
Lesson 3: Treatment as Prevention
U=U Guidance for Implementation in Clinical Settings
Undetectable = Untransmittable
Sex in the Age of PrEP and U=U
Presentation transcript:

Risk of Sexual Transmission under HAART Background information on Swiss statement Pietro Vernazza President EKAF- Swiss Federal Commission on AIDS

FB Infektiologie / Spitalhygiene Agenda Why a statement Formal content of the statement Impact on Swiss physicians and patients Influence on other clinical guidance (EU, US)

FB Infektiologie / Spitalhygiene The development of the EKAF statement Why a statement Criminal prosecution (CH > 30 cases!) Couples willing to conceive a child Discrepancy public/ private information –Problems of inconsistency of information –Risk of uncontrolled diffusion

FB Infektiologie / Spitalhygiene The risk of Transmission of HIV What do HIV d/c couples think? What is your estimate of transmission risk after one single sexual act  during fully suppressive HAART 100% - 10% - 1% - 1: : : :10 6 womenmen

FB Infektiologie / Spitalhygiene HIV-Transmission risk over time Infectiousness (arbritrary scale) Months / Years Weeks PHI STDs Vernazza, AIDS 1999;13:155–166 (adapted)

FB Infektiologie / Spitalhygiene The development of the EKAF statement Evaluation by Expert Group (FKT) High Risk  Relevant for Public Health IntermediateRisk:  Relevant for the individual NegligibleRisk:  Similar to risks of daily life Oral Sex w/o Ejac Condom, no Tx Oral Sex w/o Ejac Condom, no Tx

FB Infektiologie / Spitalhygiene Other “negligible” risk situations Condom-protected vaginal Sex:  0.9 / 100 py for always users Davis, 1999, Fam Plan Perspectives Receptive oral Sex (MSM): / act Vittinghoff, 1999, Am J. Epid  1:2‘500

FB Infektiologie / Spitalhygiene Transmission risk under ART Risk estimation Published partner studies –N<600, no Trsm  95%-CI: < 1:200 Absence of observed cases –What is the denominator? SHCS*: 20% practice unsafe sex Europe: >300’000 ART  30 x sex/year Detection rate 1%  1:100‘000 *Panozzo et al, 2003, SMW

FB Infektiologie / Spitalhygiene Activity of ART for Prevention ART is comparable to condom use Partner under HAART None Mono- / Bi- Therapy Triple- therapy Sex w/o Condom >1/Mt.<1/Mt. Always with condom Castilla, et al. JAIDS 2005; 40: Infection rate partners (%)

FB Infektiologie / Spitalhygiene Ranges of HIV transmission risks Anal sex 1 Vaginal sex 1 Sex under ART 1 Royce et al, NEJM, 1997 Ejac STD Risk per act Oral sex 3 3 Vittinghoff, 1999 Condom Use 2 2 Davis 1999

FB Infektiologie / Spitalhygiene Consider biology... STDs: epidemiologic synergy –STDs increase genital viral load –STDs increase susceptibility to HIV Genital viral load may take some more time to get below <40 cp/ml  Any Communication about safety under HAART should include statement on duration and STD

FB Infektiologie / Spitalhygiene The EKAF statement What the statement described It‘s ok. to talk about risk estimates Under optimal conditions, risk is in the range of daily life („negligible“) –Long term maximal suppression –Perfect adherence, regular checks –Absence of STDs Only the informed partner can decide on condom use  negligible: same range as for condoms * *

FB Infektiologie / Spitalhygiene (based on math. Model by Wilson et al.) Garnett &Gazzard, The Lancet, , editorialcomment In serodiscordant male couple after 100 anal contacts Swiss statement challenged confirmed

FB Infektiologie / Spitalhygiene The EKAF statement What the statement did not say No advice against using condoms No change in prevention messages

FB Infektiologie / Spitalhygiene Impact on physicians & patients Marianne, teacher, 35 years: „Thank you, for the first time in my 20 years of HIV infection I felt secure. I have been assured that I am not a danger for other people in my life. Even when I worked with children, I feared of infecting one of them“

FB Infektiologie / Spitalhygiene Court accepts Swiss statement

FB Infektiologie / Spitalhygiene Physicians in Switzerland ? In general more disclosure regarding risk behavior Discussions with partners encouraged No massive change in risk behavior noted STDs became important issue

FB Infektiologie / Spitalhygiene Reactions in Europe German Statement (AIDS Hilfe)

FB Infektiologie / Spitalhygiene Reactions in Europe French Statement (CNS)

FB Infektiologie / Spitalhygiene Reactions in Europe French Statement (CNS) On a public healthlevel –Increase efforts for HIV testing –Promoteresearch in the field of prventionthroughmedicaltreatment General Communication –Promote benefits of HIV testing and treatment Inform about risk reduction through treatment Residual risk remains For healthprofessionals –Consider treatment as a preventive measure in cases resistant to conventional prevention methods

FB Infektiologie / Spitalhygiene Swiss Position: Open information is mandatory for well educated risk management